Are peptides safe? An honest answer.

The honest answer

Peptide safety depends on four things, in this order: which peptide, what dose, where you got it, and your individual baseline. Anyone telling you "peptides are safe" without those four data points is selling something.

This article walks through each axis.

Axis 1: Which peptide

Some peptides have decades of human safety data. Sermorelin has been an FDA-approved compounded medication for decades, used in pediatric growth hormone deficiency. Semaglutide has tens of thousands of patient-years in randomized controlled trials. Tesamorelin is FDA-approved for HIV-associated lipodystrophy and has long-term safety data.

Other peptides have essentially no human safety data. BPC-157 is the most popular peptide on the planet right now. It has zero published human safety trials. Every safety claim about BPC-157 is extrapolated from animal studies, anecdote, or n=1 user reports. That doesn't mean it's dangerous. It means we don't know.

Each peptide entry on Pepdex is graded with an evidence tier — Strong, Moderate, Limited, or Anecdotal. See Evidence tiers explained for the methodology. The first thing to do before running any peptide is check that grade.

Axis 2: Dose

Dose-related side effects scale predictably for most peptides. The classic GLP class example: semaglutide at the FDA label dose ramp produces nausea in 15-20% of users transient. Semaglutide at 5x label dose, which some users self-administer for faster weight loss, produces severe nausea, vomiting, dehydration, and gallbladder events at much higher rates. The peptide didn't change. The dose did.

Most documented dose ranges on Pepdex come from clinical literature or, where no clinical literature exists, from observed user-reported protocols. The "documented range" exists for a reason. Going outside it dramatically widens the side effect profile, often without proportional benefit.

Common pattern: someone reads that "more is better" online, doubles their dose, gets side effects, and concludes "the peptide is unsafe." The peptide wasn't unsafe at the documented dose. The dose was unsafe.

Axis 3: Source

This is the biggest variable for most consumer peptide users and the one we deliberately do not turn into a vendor guide.

Things that have killed or hospitalized peptide users in documented cases: - Endotoxin contamination — bacterial breakdown products in poorly sterilized vials. Symptoms range from mild fever to septic shock. - Heavy metal contamination — peptides synthesized in poorly regulated facilities can contain traces of lead, mercury, or arsenic. - Active substance mismatch — vial labeled "BPC-157" containing a different compound, sometimes including an opioid analog. - Underdosing — vial labeled "10mg" containing 2mg, leading to user re-dosing and overshoot. - Diluent contamination — bacteriostatic water with non-sterile reconstitution.

A peptide from a serious manufacturer with a verified Certificate of Analysis is fundamentally different from a peptide from an anonymous overseas seller. Pepdex's COA literacy guide walks through how to read a Certificate of Analysis. The guide on scam vendor spotting walks through the signals that flag a fake supplier. Read both before you buy anything.

We don't tell you which vendors to use. We do tell you what the standard actually looks like.

Axis 4: Your individual baseline

Pre-existing conditions interact with peptides in predictable ways: - Active or recent cancer — growth-related peptides are contraindicated. Period. - Active diabetes or insulin use — GLP class peptides interact with hypoglycemia risk profile. - Cardiovascular disease — some peptides modulate blood pressure or heart rate. - Pregnancy or breastfeeding — almost all peptides contraindicated. - Thyroid dysfunction — interacts with several growth-related peptides. - Active autoimmune disease — TB-500 and similar tissue-modulating peptides poorly studied.

Every peptide entry on Pepdex lists the documented contraindications. That's where you start. Then you bring those notes to your doctor or specialist before deciding.

What "safe" actually means in this context

When trial data exists for a peptide at a documented dose from a quality source in an appropriate user population, the side effect profile of most peptides is genuinely narrower than NSAIDs, alcohol, or even some over-the-counter supplements.

When any of those conditions break, the safety profile widens dramatically. Most negative outcomes in the consumer peptide scene trace back to source contamination, dose escalation, or running a peptide in a contraindicated population.

What we tell every new user

1. Do not start a peptide while pregnant, breastfeeding, with active cancer, or without screening for the documented contraindications on the peptide's Pepdex page.
2. Do not exceed the documented dose range without a clear reason.
3. Verify the COA on whatever you buy, or assume the vial is mislabeled.
4. Do not stack three peptides at once when you have not run any of them solo.
5. Track baseline bloodwork before starting and 8-12 weeks in. The Pepdex bloodwork guide is at /guides/bloodwork.

That's the actual safety conversation.

Where to go next

• What are peptides? — fundamentals.
• Pepdex evidence tiers — how we grade research quality per peptide.
• Scam vendor spotting — the signals that flag a fake source.
• The 65 peptides indexed — every entry has documented contraindications and side effects.